Pharmaceutical Technology
JUNE 5, 2024
Belgian biotech, Bio-Sourcing, and Cape Town based company, Afrigen Biologics, have signed a partnership for a technology transfer pilot programme in South Africa of a biotherapeutic platform named BioMilk.
Bio Pharma Dive
JUNE 5, 2024
How can small and mid-sized biotech companies better manage pharmacovigilance during clinical trials? Listen to the podcast to learn how strategic alliances are helping.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 5, 2024
The US FDA has granted orphan drug designation to Be Biopharma’s (Be Bio) BE-101 for the treatment of haemophilia B.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 5, 2024
Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi has emphasised that the medical devices and in-vitro diagnostics (IVD) sold in the county should be tested for the standards prescribed by the Bureau of Indian Standards (BIS) for its quality and performance in the country.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
JUNE 5, 2024
5 June marks World Environment Day, an annual celebration that encourages global awareness and action to protect the environment.
AuroBlog - Aurous Healthcare Clinical Trials blog
JUNE 5, 2024
Scientists are learning about the pros and cons of Ozempic in real-time, as prescriptions of the appetite-suppressing drug explode into the millions worldwide.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Rethinking Clinical Trials
JUNE 5, 2024
Dr. Russell Rothman and Dr. Jason Block In this Friday’s PCT Grand Rounds, Russell Rothman of Vanderbilt University Medical Center and Jason Block of Harvard Medical School will present “The NIH COvid-19 and Diabetes Assessment (CODA) Study: Leveraging PCORnet for a Novel Cohort Study.” The Grand Rounds session will be held on Friday, June 7, 2024, at 1:00 pm eastern.
Bio Pharma Dive
JUNE 5, 2024
Anat Ashkenazi is switching industries after a 23-year career at the Indianapolis drugmaker.
Pharmaceutical Technology
JUNE 5, 2024
Having a competent and efficient partner by your side can elevate your mass production to new levels of efficiency and sustainable success.
Fierce Pharma
JUNE 5, 2024
The scope of Bristol Myers Squibb’s $1.5 billion savings drive is beginning to come into focus. | Starting this month, BMS will begin the process of laying off around 863 employees in Lawrenceville, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) alert from the state. The move forms part of BMS’ campaign to shave off $1.5 billion in costs by the end of 2025, a company spokesperson said over email.
Pharmaceutical Technology
JUNE 5, 2024
The biopharma shared preliminary Phase II data at EASL for its IgG1 monoclonal antibody, BJT-778
Pharma Times
JUNE 5, 2024
Extended phase 2 study highlights macrophage cell therapy’s efficacy
Pharmaceutical Technology
JUNE 5, 2024
AbbVie's RINVOQ is now indicated for polyarticular juvenile idiopathic arthritis (pJIA) and psoriatic arthritis (PsA) in paediatric patients.
Fierce Pharma
JUNE 5, 2024
After 23 years at Eli Lilly, including the last three as its CFO, Anat Ashkenazi is leaving to take the same role at Google's parent company Alphabet.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JUNE 5, 2024
An FDA advisory committee, whilst noting improvement in patient symptoms, was not convinced by Lykos’ trial design.
Pharma Times
JUNE 5, 2024
Phase 3 research suggests a significant leap forward in myeloma management
Pharmaceutical Technology
JUNE 5, 2024
AstraZeneca has announced the conclusion of its acquisition of clinical-stage biopharmaceutical company Fusion Pharmaceuticals.
pharmaphorum
JUNE 5, 2024
An initiative set up by the FDA to accelerate the development of therapies for rare disease in the same way that Operation Warp Speed delivered COVID-19 vaccine has chosen its first pilot programme candidates.
Pharmaceutical Technology
JUNE 5, 2024
Johnson & Johnson has sought approval from the US FDA for the use of its HIV-1 therapy, PREZCOBIX, in children aged six years and above.
pharmaphorum
JUNE 5, 2024
KRAS inhibitors from Eli Lilly, Genfleet, and InxMed make their case for use in NSCLC at ASCO, as they case down Amgen and Bristol-Myers Squibb's market drugs
Fierce Pharma
JUNE 5, 2024
Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease. | Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease.
pharmaphorum
JUNE 5, 2024
PHTI's latest report finds that digital therapies for musculoskeletal conditions like low back pain can deliver clinically meaningful benefits
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharmaceutical Commerce
JUNE 5, 2024
The latest news for pharma industry insiders.
pharmaphorum
JUNE 5, 2024
Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term efficacy and safety.
Pharmaceutical Commerce
JUNE 5, 2024
The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.
pharmaphorum
JUNE 5, 2024
NHS hospitals in London have declared a critical incident caused by a ransomware attack on a pathology services provider, leading to cancelled procedures and patients having to be transferred to different care providers. The attack on Synnovis has had an impact on patient care at Guy’s and St Thomas’ and King’s College Hospital NHS Foundation Trusts, as well as GP services in southeast London, according to an NHS England statement.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Pharmaceutical Technology
JUNE 5, 2024
FDA officials outline what to expect at the upcoming hearing on AdComs, and elaborated how the right data can drive accelerated approvals.
BioSpace
JUNE 5, 2024
There are multiple ways biopharmas create inclusive workplaces for LGBTQ+ employees, and they go beyond employee resource groups and benefits.
BioPharma Reporter
JUNE 5, 2024
Get ready for a big reveal at the DIA conference in San Diego as GiftHealth introduces its latest AI-enabled features designed to revolutionize patient care.
BioSpace
JUNE 5, 2024
Amgen’s CD19-directed antibody Uplizna in a late-stage study showed it can suppress the risk of flares by nearly 90% in patients with IgG4-related disease, the company announced Wednesday.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
130 
Let's personalize your content